TOWA PHARMACEUTICAL CO.,LTD. [4553.T]
TOKYO, May 11 (Pulse News Wire) – TOWA PHARMACEUTICAL CO.,LTD. (4553) has revised its FY2026/3 Full-Year consolidated earnings forecast. FORECAST REVISION SUMMARY: (Unit: ) Revenue Op Profit Ord Profit Net Profit Previous Forecast (A) 280,000 27,000 25,300 17,700 Revised Forecast (B) 273,700 23,100 28,000 5,200 Change (B-A) -6,300 -3,900 2,700 -12,500 Change (%): Revenue -2.3% | OP -14.4% | OrdP +10.7% | NP -70.6% Prior Year Actual 259,594 23,242 26,152 18,986 KEY CHANGES: - Revenue forecast lowered by +2.3% to 273,700 - Net profit forecast lowered by +70.6% to 5,200 - Operating profit forecast lowered by +14.4% to 23,100 REASON FOR REVISION: 20263 53 147 20263 2027362024-2026PROACTIVE Ⅲ 514 DIVIDEND REVISION: The company also revised its dividend forecast.
🟢 Confidence: High AI-translated content.